Novartis teams with India’s Biological E for typhoid vaccine development

An article from VaccineNation
July 10, 2013
Novartis teams with India’s Biological E for typhoid vaccine development

 

July 10, 2013--Novartis and the Indian biotechnology company Biological E have made a development and licensing agreement to offer accessible and affordable typhoid and paratyphoid A vaccines to the developing world. This would be the first vaccine available for paratyphoid A. Novartis, through its Novartis Vaccines Institute for Global Health (NVGH) will undertake "the translational research required to gain human Proof of Concept" and will provide this research to manufacturers to help reduce the risks and costs of vaccine development. Read more here, or access the Novartis press release here.

Common Disease Taxonomy: 
Common Vaccine Taxonomy: